US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

IMRA

IMARA (IMRA)

IMARA Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:IMRA

1 2 3 4 5 6 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/02/24	06 : 06	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IMRA	IMARA Inc
2023/02/23	06 : 51	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:IMRA	IMARA Inc
2023/02/23	06 : 47	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:IMRA	IMARA Inc
2023/02/23	06 : 01	GlobeNewswire Inc.	Imara Announces Stockholder Approval of Merger With Enliven	NASDAQ:IMRA	IMARA Inc
2023/02/22	06 : 06	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:IMRA	IMARA Inc
2023/02/22	06 : 06	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:IMRA	IMARA Inc
2023/02/15	07 : 08	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:IMRA	IMARA Inc
2023/02/15	06 : 19	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:IMRA	IMARA Inc
2023/02/14	07 : 10	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:IMRA	IMARA Inc
2023/02/14	07 : 07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:IMRA	IMARA Inc
2023/02/11	06 : 10	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:IMRA	IMARA Inc
2023/02/09	06 : 17	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:IMRA	IMARA Inc
2023/02/02	08 : 27	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IMRA	IMARA Inc
2023/02/02	08 : 25	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IMRA	IMARA Inc
2023/01/09	20 : 02	Edgar (US Regulatory)	Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)	NASDAQ:IMRA	IMARA Inc
2022/12/30	08 : 18	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IMRA	IMARA Inc
2022/12/27	23 : 35	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IMRA	IMARA Inc
2022/12/13	06 : 31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IMRA	IMARA Inc
2022/12/06	06 : 34	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:IMRA	IMARA Inc
2022/12/06	06 : 32	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:IMRA	IMARA Inc
2022/11/16	20 : 02	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:IMRA	IMARA Inc
2022/11/11	06 : 29	Edgar (US Regulatory)	Securities Registration: Business Combination (s-4)	NASDAQ:IMRA	IMARA Inc
2022/11/11	06 : 22	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:IMRA	IMARA Inc
2022/10/26	05 : 18	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:IMRA	IMARA Inc
2022/10/25	05 : 43	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:IMRA	IMARA Inc
2022/10/25	05 : 32	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:IMRA	IMARA Inc
2022/10/20	05 : 41	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IMRA	IMARA Inc
2022/10/20	05 : 31	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:IMRA	IMARA Inc
2022/10/15	01 : 13	TipRanks	Imara Merging With Enliven, Shares Pop	NASDAQ:IMRA	IMARA Inc
2022/10/14	19 : 31	TipRanks	Analysts’ Opinions Are Mixed on These Healthcare Stocks: Inovio Pharmaceuticals (INO), Crinetics Pharmaceuticals (CRNX) and IMARA (IMRA)	NASDAQ:IMRA	IMARA Inc

Showing the most relevant articles for your search:NASDAQ:IMRA

1 2 3 4 5 6 次へ >>

GBM Resources (PK)

Amundi Euro Inflation Ex...

BNP Paribas Issuance

Innovator Deepwater Fron...

Mildef Group AB

Deep Value Dividend Port...

BlackRock Global Funds

Bnp Paribas Issuance

Bnp Paribas Issuance

BNP Paribas Issuance

Greenland Resources (PK)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約